Cavoley
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cavoley, covering 2017-06-27 to 2019-04-05. Get the full timeline:
Most recent: EMA Application withdrawn: Cavoley (pegfilgrastim) — Stada Arzneimittel AG